These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 3816112)

  • 41. [Pre- and postoperative splanchnic hemodynamics measured by indocyanine green clearance in patients with portal hypertension].
    Song Y
    Zhonghua Wai Ke Za Zhi; 1991 Nov; 29(11):669-72, 717. PubMed ID: 1818801
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Indocyanine green clearance in acute rejection after liver transplantation.
    Clements D; McMaster P; Elias E
    Transplantation; 1988 Sep; 46(3):383-5. PubMed ID: 3047928
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The effect of single doses of cimetidine on estimated hepatic blood flow.
    Rocci ML; Grasela DM; Fruncillo RJ; Vlasses PH
    Drug Intell Clin Pharm; 1985 Nov; 19(11):831-4. PubMed ID: 4064917
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Plasma elimination of indocyanine green in the intact pig after bolus injection and during constant infusion: comparison of spectrophotometry and high-pressure liquid chromatography for concentration analysis.
    Ott P; Keiding S; Bass L
    Hepatology; 1993 Dec; 18(6):1504-15. PubMed ID: 8244277
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The validation of auricular densitometry for indocyanine green clearance measurement of hepatic blood flow during and after cardiopulmonary bypass in children.
    Mitchell IM; Pollock JC; Jamieson MP
    Perfusion; 1995 Jul; 10(4):197-208. PubMed ID: 7488765
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Nicardipine increases hepatic blood flow and the hepatic clearance of indocyanine green in patients with cirrhosis.
    García-Pagán JC; Feu F; Luca A; Fernández M; Pizcueta P; Bosch J; Rodés J
    J Hepatol; 1994 Jun; 20(6):792-6. PubMed ID: 7930480
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [The effect of glucagon on hepatic blood flow and ICG excretion].
    Yasuda Y
    Nihon Geka Gakkai Zasshi; 1987 Jan; 88(1):63-73. PubMed ID: 3821716
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Circadian changes in estimated hepatic blood flow in healthy subjects.
    Lemmer B; Nold G
    Br J Clin Pharmacol; 1991 Nov; 32(5):627-9. PubMed ID: 1954078
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clearance of indocyanine green in dogs with partial hepatectomy, hepatic duct ligation, and passive hepatic congestion.
    Rakich PM; Prasse KW; Bjorling DE
    Am J Vet Res; 1987 Sep; 48(9):1353-7. PubMed ID: 3662206
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Changes in indocyanine green kinetics after the administration of enalapril to healthy subjects.
    Geneve J; Le Dinh T; Brouard A; Bails M; Segrestaa JM; Caulin C
    Br J Clin Pharmacol; 1990 Aug; 30(2):297-300. PubMed ID: 2206792
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Methodological limitations of the use of intrinsic hepatic clearance of ICG as a measure of liver cell function.
    Keiding S; Skak C
    Eur J Clin Invest; 1988 Oct; 18(5):507-11. PubMed ID: 3147903
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The influence of nifedipine and captopril on liver blood flow in healthy subjects.
    Burggraaf J; Schoemaker RC; Kroon JM; Cohen AF
    Br J Clin Pharmacol; 1998 May; 45(5):447-51. PubMed ID: 9643616
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Hepatic parenchymal cell volume and the indocyanine green tolerance test.
    Hashimoto M; Watanabe G
    J Surg Res; 2000 Aug; 92(2):222-7. PubMed ID: 10896825
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Changes in hepatic blood flow during whole body hyperthermia.
    Deja M; Ahlers O; Macguill M; Wust P; Hildebrandt B; Riess H; Kerner T
    Int J Hyperthermia; 2010; 26(2):95-100. PubMed ID: 20146563
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Plasma disappearance of indocyanine green: a marker for excretory liver function?
    Stehr A; Ploner F; Traeger K; Theisen M; Zuelke C; Radermacher P; Matejovic M
    Intensive Care Med; 2005 Dec; 31(12):1719-22. PubMed ID: 16231068
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The effect of PGE2 on hepatic blood flow and bile indocyanin green in the rat.
    Bruck R; Krepel Z; Melzer E; Bar-Meir S
    Prostaglandins; 1989 May; 37(5):531-8. PubMed ID: 2740524
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effects of ranitidine on plasma clearance of indocyanine green in patients with liver cirrhosis.
    Kosaka Y; Tameda Y; Okita K; Takemoto T; Sato S; Okuda K; Kameda H; Yamamoto S; Kamada T; Muto Y
    Gastroenterol Jpn; 1987 Dec; 22(6):737-42. PubMed ID: 3443254
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The acute and chronic effects of H1 receptor blockade with astemizole on indocyanine green clearance.
    Bateman DN; Chapman PH; Rawlins MD
    Br J Clin Pharmacol; 1983 Sep; 16(3):241-4. PubMed ID: 6138054
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effect of changes in liver blood flow on the pharmacokinetics of saruplase in patients with acute myocardial infarction.
    van Griensven JM; Koster RW; Hopkins GR; Beier H; Günzler WA; Kroon R; Schoemaker RC; Cohen AF
    Thromb Haemost; 1997 Sep; 78(3):1015-20. PubMed ID: 9308746
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effects of smoking and chronic hepatitis B on lidocaine and indocyanine green kinetics.
    Huet PM; Lelorier J
    Clin Pharmacol Ther; 1980 Aug; 28(2):208-15. PubMed ID: 7398188
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.